Our mission is to care and cure.

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.

Research Grants 421 show all


$100.1M
2015

$46.4M
2016

$108.1M
2017

$205.1M
2018

$142.2M
2019

Publications 287 show all

  • 14
    Aldehyde Reductase/antagonists & inhibitors
  • 10
    Lenses, Intraocular
  • 9
    Contact Lenses, Hydrophilic
  • 7
    Hydantoins/pharmacokinetics
  • 7
    Intraocular Pressure/drug effects
  • 7
    Lens, Crystalline/metabolism
  • 7
    Sugar Alcohol Dehydrogenases/antagonists & inhibitors
  • 6
    Cornea/metabolism
  • 6
    Fluorenes/pharmacokinetics
  • 6
    Histamine H1 Antagonists/pharmacology

Patents 144,545show all

  • 19,272
    C07D - Heterocyclic compounds
  • 17,010
    A61K - Preparations for medical, dental, or toilet purposes
  • 8,000
    C07C - Acyclic or carbocyclic compounds
  • 6,852
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 6,106
    C09B - Organic dyes or closely-related compounds for producing dyes
  • 5,156
    C07K - Peptides
  • 4,254
    C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients
  • 4,214
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4,086
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 3,524
    A61F - Filters implantable into blood vessels

Clinical Trials 7,503show all

2,095Phase 31,848Phase 21,302N/A976Phase 4630Phase 1426Other

Contact Information

Basel
Switzerland